Atrium Therapeutics, Inc. · NASDAQ:RNA
Younis Husam received 30,000 Atrium Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Younis Husam (Chief Scientific Officer) received 30,000 Atrium Therapeutics, Inc. shares as an award, leaving 52,657 shares. Filed Apr 22, 2026 (Form 4).
- Awarded
- 30,000 shares
- Holding after
- 52,657 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Award | 30,000 | 52,657 | Direct |
Source
Related
- Atrium Therapeutics, Inc.
- Younis Husam
- Atrium Therapeutics, Inc. shareholders
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026
- Form 4 · Gallagher Kathleen P. · Sep 22, 2026